Celldex Therapeutics | CLDX - Pasivo Circulante





Pasivo Circulante Cambio Fecha
AbbVie USD 42.1B 1.19B 2026-03
Agenus USD 249.24M 74.25M 2026-03
Amgen USD 24.96B 534M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Celldex Therapeutics USD 51.47M 481K 2026-03
Glaxosmithkline GBP 28.82B 144.79M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Northwest Biotherapeutics USD 87.9M 3.98M 2025-09
Pfizer USD 34.35B 2.64B 2026-03
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28B 421M 2025-12